This content is only available as a PDF.

Author notes

Data sharing statement: The datasets generated during and/or analyzed during the current study are available from Toshiki Terao on reasonable request.

© 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
2025

Article PDF first page preview

First page of Three-year follow-up of low-dose, early-start gilteritinib maintenance in posttransplant patients with R/R FLT3mut AML